Registrations open for Australia’s premier biotech investment and capital raising event
AusBiotech and Beacon Events have joined forces to launch Australia’s premier event for biotech investment and capital raising - Australia Biotech Invest.
To be held from 28-29 October 2013 at the Melbourne Convention Centre, the conference will bring world-leading biotech innovators together with Australia’s investment community to discover and fund the future of biotech.
Featuring a mix of expert keynotes and biotech company presentations, the conference merges market intelligence with investment opportunities and will act as your guide to successful biotech investment.
Australia Biotech Invest features a limited number of company spotlight slots, offering biotech companies the opportunity to showcase their product pipeline and its investment potential to the assembled audience of investors, venture capitalists, financiers and potential JV partners.
Registrations are open for investors wishing to attend and attendance is free for qualified investors. Sponsorship packages are also available now.
See www.ausbiotechinvest.com for more information or contact Hayley Laing at hlaing@ausbiotech.org.
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
